scPharmaceuticals Inc. (SCPH) Financial Statements (2026 and earlier)

Company Profile

Business Address 25 BURLINGTON MALL ROAD, SUITE 203
BURLINGTON, MA 01803
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

6/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments75,65576,013118,18675,278105,09572,624
Cash and cash equivalent75,65546,81471,06174,26871,81972,624
Short-term investments  29,19947,1251,01033,276 
Restricted cash and investments   182182  
Receivables11,7214,489   310
Inventory, net of allowances, customer advances and progress billings13,9038,8401,230   
Inventory13,9038,8401,230   
Prepaid expense3,5492,4362,2822,7912,6102,619
Other current assets    2412194
Other undisclosed current assets1,0211,1601,428   
Total current assets:105,84992,938123,30878,275107,82675,647
Noncurrent Assets
Operating lease, right-of-use asset1,2731,4015664108151,179
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization5658546993127
Restricted cash and investments     182182
Other undisclosed noncurrent assets34182267283132148
Total noncurrent assets:1,6701,5418877621,2221,636
TOTAL ASSETS:107,51994,479124,19579,037109,04877,283
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14,58512,9026,8074,5396,4534,830
Accounts payable3,8834,0011,5185441,6661,142
Accrued liabilities10,7028,9015,2893,9954,7873,688
Debt    9,8052,408407
Other liabilities52564226  
Other undisclosed current liabilities239176567476460 
Total current liabilities:14,87613,1347,41614,8469,3215,237
Noncurrent Liabilities
Long-term debt and lease obligation51,35038,81136,7947,35417,33819,858
Long-term debt, excluding current maturities51,35038,81136,7947,35416,85818,915
Liabilities, other than long-term debt1,1045,3167,552367219823
Other liabilities  1772836721958
Operating lease, liability1,1041,2827 480943
Derivative instruments and hedges, liabilities  3,8577,517  765
Other undisclosed noncurrent liabilities26,869     
Total noncurrent liabilities:79,32344,12744,3467,72117,55720,681
Total liabilities:94,19957,26151,76222,56726,87825,918
Equity
Equity, attributable to parent13,32037,21872,43356,47082,17051,365
Common stock543332
Additional paid in capital379,809318,561298,934246,166243,830180,818
Accumulated other comprehensive income (loss)  (1)32(1)1 
Accumulated deficit(366,494)(281,346)(226,536)(189,698)(161,664)(129,455)
Total equity:13,32037,21872,43356,47082,17051,365
TOTAL LIABILITIES AND EQUITY:107,51994,479124,19579,037109,04877,283

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues36,33213,59347515156
Sublease income   47515156
Cost of revenue(11,361)(3,811)    
Gross profit:24,9719,78247515156
Operating expenses(101,108)(68,989)(36,157)(25,823)(29,933)(32,905)
Other undisclosed operating income (loss)11,3613,811(47)(51)(51)(56)
Operating loss:(64,776)(55,396)(36,157)(25,823)(29,933)(32,905)
Nonoperating income7,0778,7092,6213643111,676
Investment income, nonoperating3,4445,1041,203493151,660
Other nonoperating income (expense)3,6333,6051,418315(4)16
Interest and debt expense(13,032)(8,123)(3,302)(2,575)(2,587)(1,767)
Loss from continuing operations:(70,731)(54,810)(36,838)(28,034)(32,209)(32,996)
Loss before gain (loss) on sale of properties:✕✕✕✕(28,034)(32,209)(32,996)
Other undisclosed net loss(14,417)     
Net loss available to common stockholders, diluted:(85,148)(54,810)(36,838)(28,034)(32,209)(32,996)

Comprehensive Income ($ in thousands)
Annual | Quarterly

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(85,148)(54,810)(36,838)(28,034)(32,209)(32,996)
Comprehensive loss:(85,148)(54,810)(36,838)(28,034)(32,209)(32,996)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 1(33)33(2)1 
Comprehensive loss, net of tax, attributable to parent:(85,147)(54,843)(36,805)(28,036)(32,208)(32,996)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: